Tap to start →
Photo: Vitaly Gariev / Unsplash
1 / 3
MariTide is an investigational Amgen injection, given monthly or less often, that activates the GLP-1 receptor while blocking the GIP receptor.
2 / 3
MariTide links two GLP-1 peptides to an antibody that blocks the GIP receptor.
3 / 3
If approved, MariTide could change dosing from weekly to monthly, which matters for people who struggle with frequent shots.
MariTide is an investigational Amgen injection, given monthly or less often, that activates the GLP-1 receptor while blocking the GIP receptor.
Tap below for the full page. Not medical advice; talk to your clinician about your care.